Page last updated: 2024-08-26

2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine and Adenocarcinoma

2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Marzo, AM; Groopman, JD; Isaacs, WB; Kensler, TW; Kidd, LC; Nelson, CP; Nelson, WG; Sauvageot, J1

Other Studies

1 other study(ies) available for 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine and Adenocarcinoma

ArticleYear
Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1.
    Cancer research, 2001, Jan-01, Volume: 61, Issue:1

    Topics: Adenocarcinoma; Aged; Biotransformation; Carcinogens; Cytosol; DNA; DNA Adducts; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Imidazoles; Isoenzymes; Male; Middle Aged; Prostate; Prostatic Neoplasms; Pyridines; Transfection; Tumor Cells, Cultured

2001